🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06707974
Starting soon Observational

Prognostic Study of Via Dynamic Change of dT-DNA in Drainage Fluid After Radical Prostatectomy

NCT06707974 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase
Observational
Started
2024-12-01
Last updated
2024-11-27

Condition(s) studied

Prostatic NeoplasmsctDNA

Study summary

This study investigates the prognostic value of dynamic changes in Drainage Tumor DNA(dT-DNA) levels found in the peritoneal drainage fluid after radical prostatectomy. Prostate cancer is one of the most common cancers in men, and radical prostatectomy is a standard treatment. While PSA levels in the blood are commonly used as a marker for diagnosis, this study focuses on the significance of dT-DNA levels in the prognosis of prostate cancer. The findings may provide insights into improved post-surgical monitoring and more tailored therapeutic strategies for prostate cancer patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Prostate cancer patients treated with radical prostatectomy Exclusion Criteria: * 1\. Received neoadjuvant endocrine/chemotherapy before surgery; * 2\. Urine leakage after surgery (positive creatinine test of drainage fluid).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai General Hospital Shanghai Shanghai Municipality

More Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06707974 on ClinicalTrials.gov ↗ ← All trials in China